Table 3.

Oral health, use of medication, smoking, and alcoholism in patients with HIV infection and controls.

Variables	Case Group N (%)	Control Group N (%)	Total (%)	P value	Odds rate	CI 95%
Oral Health
Periodontal diseases	23 (69.7)	10 (30.3)	33 (100)	0.003*	3.614	1.498–8.720
Coated tongue	32 (64)	18 (36)	50 (100)	0.003*	3.368	1.511–7.508
Residual root	16 (100)	0 (0)	16 (100)	0.000*	0.393	0.304–0.309
Dry mucosa	9 (69.2)	4 (30.8)	13 (100)	0.111*	2.679	0.770–9.323
Lost teeth	35 (70)	15 (30)	50 (100)	0.000*	5.688	2.457–13.165
Atrophic glossitis	8 (100)	0 (0)	8 (100)	0.002**	0.443	0.355–0.554
Oral ulcer	7 (100)	0 (0)	7 (0)	0.005**	0.449	0.361–0.559
Melanic hyperpigmentation	10 (90.9)	1 (9.1)	11 (100)	0.003*	12.927	1.590–105.105
Hairy tongue	1 (100)	0 (100)	1 (100)	0.486**	0.481	0.394–0.587
Herpes zoster	1 (100)	0 (100)	1 (100)	0.486**	0.481	0.394–0.587
Oral candidose	12 (100)	0 (0)	12 (100)	0.000*	0.419	0.330–0.533
HIV Infection
Positive	47 (100)	0 (0)	47 (100)	-	-	-
Use of medication
Antirretroviral drugs	34 (66)	0 (0)	34	-	-	-
Abacavir	1 (1.9)	0 (0)	1	-	-	-
Atazanavir	10 (19.6)	0 (0)	10	-	-	-
Didanosine	1 (1.9)	0 (0)	1	-	-	-
Efavirenz	13 (25.4)	0 (0)	13	-	-	-
Fosamprenavir	1 (1.9)	0	1	-	-	-
Lamivudine	23 (45)	0	23	-	-	-
Lopinavir	6 (11.7)	0 (0)	6	-	-	-
Norvir	1 (1.9)	0 (0)	-	-	-	-
Ritonavir	14 (27.4)	0 (0)	-	-	-	-
Tipranavir	1 (1.9)	0 (0)	-	-	-	-
Tenofovir	24 (47)	0 (0)	-	-	-	-
Zidovudine	5 (9.8)	0 (0)	-	-	-	-
Addictions
Smoking	8 (50)	8 (50)	16 (100)	-	-	-
Alcoholism	14 (70)	6 (30)	20 (100)	-	-	-

^*>Chi-squared test (p<0.05)

^**Fisher's exact test (p<0.05)

Confidence Interval (CI)